These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1757106)

  • 1. Mechanisms involved in the evasion of the host defence by Pseudomonas aeruginosa.
    Kharazmi A
    Immunol Lett; 1991 Oct; 30(2):201-5. PubMed ID: 1757106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketogenesis favors oxidative phosphorylation to promote disease tolerance.
    Jesus K; Moita LF
    Trends Endocrinol Metab; 2024 Mar; 35(3):177-179. PubMed ID: 38302400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa biofilms: mechanisms of immune evasion.
    Alhede M; Bjarnsholt T; Givskov M; Alhede M
    Adv Appl Microbiol; 2014; 86():1-40. PubMed ID: 24377853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immune evasion of Pseudomonas aeruginosa].
    Shimada T; Matsumura I
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(1):33-41. PubMed ID: 24598066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immune system vs. Pseudomonas aeruginosa biofilms.
    Jensen PØ; Givskov M; Bjarnsholt T; Moser C
    FEMS Immunol Med Microbiol; 2010 Aug; 59(3):292-305. PubMed ID: 20579098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa alkaline protease blocks complement activation via the classical and lectin pathways.
    Laarman AJ; Bardoel BW; Ruyken M; Fernie J; Milder FJ; van Strijp JA; Rooijakkers SH
    J Immunol; 2012 Jan; 188(1):386-93. PubMed ID: 22131330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes.
    Alhede M; Bjarnsholt T; Jensen PØ; Phipps RK; Moser C; Christophersen L; Christensen LD; van Gennip M; Parsek M; Høiby N; Rasmussen TB; Givskov M
    Microbiology (Reading); 2009 Nov; 155(Pt 11):3500-3508. PubMed ID: 19643762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein.
    Kunert A; Losse J; Gruszin C; Hühn M; Kaendler K; Mikkat S; Volke D; Hoffmann R; Jokiranta TS; Seeberger H; Moellmann U; Hellwage J; Zipfel PF
    J Immunol; 2007 Sep; 179(5):2979-88. PubMed ID: 17709513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Virulence factors in Pseudomonas aeruginosa: mechanisms and modes of regulation].
    Ben Haj Khalifa A; Moissenet D; Vu Thien H; Khedher M
    Ann Biol Clin (Paris); 2011; 69(4):393-403. PubMed ID: 21896403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa evasion of phagocytosis is mediated by loss of swimming motility and is independent of flagellum expression.
    Amiel E; Lovewell RR; O'Toole GA; Hogan DA; Berwin B
    Infect Immun; 2010 Jul; 78(7):2937-45. PubMed ID: 20457788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host Responses to Biofilm.
    Watters C; Fleming D; Bishop D; Rumbaugh KP
    Prog Mol Biol Transl Sci; 2016; 142():193-239. PubMed ID: 27571696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host-microbe interactions in chronic rhinosinusitis biofilms and models for investigation.
    Vanderpool EJ; Rumbaugh KP
    Biofilm; 2023 Dec; 6():100160. PubMed ID: 37928619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming Barriers to Preventing and Treating
    Lopes JA; Rghei AD; Thompson B; Susta L; Khursigara CM; Wootton SK
    Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36551918
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing the relative importance of bacterial resistance, persistence and hyper-mutation for antibiotic treatment failure.
    Witzany C; Regoes RR; Igler C
    Proc Biol Sci; 2022 Nov; 289(1986):20221300. PubMed ID: 36350213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A previously uncharacterized gene, PA2146, contributes to biofilm formation and drug tolerance across the ɣ-Proteobacteria.
    Kaleta MF; Petrova OE; Zampaloni C; Garcia-Alcalde F; Parker M; Sauer K
    NPJ Biofilms Microbiomes; 2022 Jul; 8(1):54. PubMed ID: 35798749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Depletion Mechanism Actuates Bacterial Aggregation by Exopolysaccharides and Determines Species Distribution & Composition in Bacterial Aggregates.
    Secor PR; Michaels LA; Bublitz DC; Jennings LK; Singh PK
    Front Cell Infect Microbiol; 2022; 12():869736. PubMed ID: 35782109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of an engineered mucus microenvironment for in vitro modeling of host-microbe interactions.
    Huang AJ; O'Brien CL; Dawe N; Tahir A; Scott AJ; Leung BM
    Sci Rep; 2022 Apr; 12(1):5515. PubMed ID: 35365684
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Keating T; Lethbridge S; Allnutt JC; Hendon-Dunn CL; Thomas SR; Alderwick LJ; Taylor SC; Bacon J
    Cell Surf; 2021 Dec; 7():100065. PubMed ID: 34778603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elastase Activity From Pseudomonas aeruginosa Respiratory Isolates and ICU Mortality.
    Zupetic J; Peñaloza HF; Bain W; Hulver M; Mettus R; Jorth P; Doi Y; Bomberger J; Pilewski J; Nouraie M; Lee JS
    Chest; 2021 Nov; 160(5):1624-1633. PubMed ID: 33878342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Responses to
    Moser C; Jensen PØ; Thomsen K; Kolpen M; Rybtke M; Lauland AS; Trøstrup H; Tolker-Nielsen T
    Front Immunol; 2021; 12():625597. PubMed ID: 33692800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.